Éliminante régulière 1,5 g
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
Se questo prodotto fosse venduto in Francia
- Conditions légales
Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte | Massimo giornaliero, adulto |
|---|---|---|
| Senna alexandrina Fonte : Feuille | 500 mg | Non calcolata |
| Uncaria tomentosa Fonte : Racine | 30 mg | Non calcolata |
| Capsicum annuum Fonte : Capsicum annuum - fruit | 15 mg | Non calcolata |
| Malva verticillata Fonte : Malva verticillata - Feuille | 880 mg | Non calcolata |
Ingredienti non medicinali
Réglisse séchée, Saveur de citron
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes | Non précisée | 1 tea bag | 1 Tous les jours |
Usi autorizzati in Canada
Capsicum annuum est utilisé traditionnellement en phytothérapie pour aider à la digestion. Le Séné est utilisé traditionnellement en phytothérapie comme laxatif stimulant pour faciliter l'évacuation intestinale et le soulagement à court-terme de la constipation occasionnelle.
Testo originale in francese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Effets indésirables connus : Cesser l'utilisation si une hypersensibilité/allergie se manifeste. Cessez l'utilisation et consulter un praticien de soins de santé immédiatement en cas d'étourdissement, de confusion mentale, de faiblesse ou de douleur musculaire, de rythme cardiaque irrégulier et/ou de difficulté à respirer. En cas de surdosage ou d¿ingestion accidentelle, appeler un Centre antipoison immédiatement.
Testo originale in francese.
Précautions et mises en garde : Consulter un praticien de soins de santé/fournisseur de soins de santé/professionnel de la santé/ docteur/médecin si les symptômes persistent ou s'aggravent. Consulter un praticien de soins de santé/fournisseur de soins de santé/professionnel de la santé/docteur/médecin avant d'en faire l'usage si vous prenez des médicaments pour le coeur, tels que des glycosides cardiaques ou des anti-arythmisants, des diurétiques thiazidiques, des corticostéroïdes, de la racine de réglisse, tout autre médicament ou produit de santé qui peut aggraver le déséquilibre des niveaux d'électrolytes. Consulter un praticien des soins de santé/fournisseur de soins de santé/professionnel de la santé/docteur/médecin avant d'en faire l'usage si vous souffrez de troubles rénaux, d'un fécalome ou de symptômes tels que des douleurs abdominales, des nausées, des vomissements ou de la fièvre. Réduire la dose ou cesser l'utilisation si vous éprouvez de la douleur abdominale, des crampes, des spasmes et/ou de la diarrhea. Garder hors de portée des enfants. Consulter un praticien en soin de santé/fournisseurs de soins de santé/professionnel de la santé/docteur/médecin avant d'en faire usage si vous souffrez d'ulcères d'estomac ou d'inflammation. Consulter un praticien de soins de santé avant l'utilisation si vous souffrez d'un désordre du système immunitaire (i.e. myasthénie grave, sclérose en plaque, arthrite rhumatoïdes lupus systémique. VIH/SIDA, etc) de cancer, d'asthme, si vous prenez des immunosuppresseurs ou si vous souffrez d'allergies sévères.
Testo originale in francese.
Contre-indications : Ne pas utiliser ce produit si vous souffrez de constrictions anormales du tractus gastro-intestinal, d'une occlusion intestinale existante ou potentielle, d¿un intestin paresseux, d¿une appendicite, d¿une maladie inflammatoire du côlon telle que la maladie de Crohn ou la colite ulcéreuse, d¿une douleur abdominale d¿origine inconnue, de saignements rectaux non diagnostiqués, de déshydratation sévère avec pertes en eau et en électrolytes ou de diarrhée. Ne pas utiliser ce produit si vous êtes enceinte ou si vous allaitez..
Testo originale in francese.
Scheda del prodotto
- Titolare
- Virage Santé Inc.
- NPN o DIN-HM
- 80118610
- Stato
- Licenza attiva
- Data della licenza
- 13 maggio 2022
- Data di revisione
- Non indicata
- Forma
- Sachet de thé
- Via di somministrazione
- Orale
- Tipo di domanda
- Générale (non traditionelle)
Fonte
Scheda ufficiale Health Canada, licenza 80118610
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
Avvertenze ufficiali (Health Canada)
Health Canada pubblica avvertenze su questi ingredienti:
- Senna alexandrina
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
SENNA - SENNA ALEXANDRINA
Via di somministrazione: Oral
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder or a lazy bowel (EMA 2018a,b; Brinker 2010; Blumenthal et al. 2000; WHO 1999).
Fonti citate da Health Canada (5)
- Blumenthal M, Goldberg A, Brinkmann J, éditeurs. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018a: European Medicines Agency. Community Herbal Monograph on Cassia Senna L., fructus and Cassia angustifolia Vahl, fructus. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 25 September 2018. [Accessed 2024 January 10]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-senna-alexandrina-mill-cassia-senna-l-cassia-angustifolia-vahl-fructus-revision-1_en.pdf
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la Santé (OMS). WHO Monographs on Selected Medicinal Plants, Volume 1. Genève (CH): Organisation mondiale de la Santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking heart medications, corticosteroids, diuretics, or other health products that may contribute to electrolyte imbalance (EMA 2018a,b; Brinker 2010; Blumenthal et al. 2000; WHO 1999).
Fonti citate da Health Canada (5)
- Blumenthal M, Goldberg A, Brinkmann J, éditeurs. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018a: European Medicines Agency. Community Herbal Monograph on Cassia Senna L., fructus and Cassia angustifolia Vahl, fructus. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 25 September 2018. [Accessed 2024 January 10]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-senna-alexandrina-mill-cassia-senna-l-cassia-angustifolia-vahl-fructus-revision-1_en.pdf
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la Santé (OMS). WHO Monographs on Selected Medicinal Plants, Volume 1. Genève (CH): Organisation mondiale de la Santé; 1999.
Controindicazioni
Do not use if you are pregnant or breastfeeding (EMA 2018a,b; Brinker 2010; Blumenthal et al. 2000).
Fonti citate da Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, éditeurs. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018a: European Medicines Agency. Community Herbal Monograph on Cassia Senna L., fructus and Cassia angustifolia Vahl, fructus. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 25 September 2018. [Accessed 2024 January 10]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-senna-alexandrina-mill-cassia-senna-l-cassia-angustifolia-vahl-fructus-revision-1_en.pdf
Do not use if you have inflammatory bowel disease, fever or any undiagnosed gastrointestinal trouble (EMA 2018a,b; Gardner and McGuffin 2013; Brinker 2010; WHO 1999).
Fonti citate da Health Canada (5)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018a: European Medicines Agency. Community Herbal Monograph on Cassia Senna L., fructus and Cassia angustifolia Vahl, fructus. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 25 September 2018. [Accessed 2024 January 10]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-senna-alexandrina-mill-cassia-senna-l-cassia-angustifolia-vahl-fructus-revision-1_en.pdf
- Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la Santé (OMS). WHO Monographs on Selected Medicinal Plants, Volume 1. Genève (CH): Organisation mondiale de la Santé; 1999.
Reazioni avverse note
Stop use if hypersensitivity/allergy or diarrhoea occurs (EMA 2018a,b; Blumenthal et al. 2000; WHO 1999).
Fonti citate da Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, éditeurs. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- EMA 2018a: European Medicines Agency. Community Herbal Monograph on Cassia Senna L., fructus and Cassia angustifolia Vahl, fructus. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 25 September 2018. [Accessed 2024 January 10]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-senna-alexandrina-mill-cassia-senna-l-cassia-angustifolia-vahl-fructus-revision-1_en.pdf
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la Santé (OMS). WHO Monographs on Selected Medicinal Plants, Volume 1. Genève (CH): Organisation mondiale de la Santé; 1999.
- Capsicum annuum
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
CAYENNE - CAPSICUM ANNUUM Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).
Fonti citate da Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).
Fonti citate da Health Canada (2)
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).
Fonti citate da Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Condizione di applicazione: Digestion; Peripheral circulation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografia di Health Canada del 27 marzo 2026
CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical
Precauzioni e avvertenze
Condizione di applicazione: All products.
For external use only (US FDA 2023).
Fonti citate da Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 studio citato nel testo non ha un riferimento corrispondente nella monografia (vedi le anomalie nella pagina delle fonti).
When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).
Fonti citate da Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 studio citato nel testo non ha un riferimento corrispondente nella monografia (vedi le anomalie nella pagina delle fonti).
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).
Fonti citate da Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 studio citato nel testo non ha un riferimento corrispondente nella monografia (vedi le anomalie nella pagina delle fonti).
Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).
Fonti citate da Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Reazioni avverse note
Condizione di applicazione: All products.
Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).
Fonti citate da Health Canada (5)
- APhA 2002: Berardi RR, DeSimone EM, Newton GGD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An interactive approach to self-care. 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- Brayfield A, Cadart C, editors. Martindale: The Complete Drug Reference. London (GB): Pharmaceutical Press; 2024. [Accessed 2024 August 14]. Available from: https://www.medicinescomplete.com/#/browse/martindale
- Hoffman D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
- McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 2000;49:574-579. PubMed Studio randomizzato
- Zhang W, Moskowitz, RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008;16:137-162. PubMed Revisione sistematica
Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.
La data della prova di questo elenco di ingredienti è sconosciuta.
Il prodotto è cambiato? Fotografi la confezione.
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.